GR3024638T3 - Method for insuring adequate intracellular glutathione in tissue - Google Patents

Method for insuring adequate intracellular glutathione in tissue

Info

Publication number
GR3024638T3
GR3024638T3 GR970402276T GR970402276T GR3024638T3 GR 3024638 T3 GR3024638 T3 GR 3024638T3 GR 970402276 T GR970402276 T GR 970402276T GR 970402276 T GR970402276 T GR 970402276T GR 3024638 T3 GR3024638 T3 GR 3024638T3
Authority
GR
Greece
Prior art keywords
tissue
intracellular glutathione
insuring adequate
glutathione
adequate intracellular
Prior art date
Application number
GR970402276T
Other languages
Greek (el)
English (en)
Inventor
David A Mark
W Bruce Rowe
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of GR3024638T3 publication Critical patent/GR3024638T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GR970402276T 1991-02-04 1997-09-04 Method for insuring adequate intracellular glutathione in tissue GR3024638T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65022291A 1991-02-04 1991-02-04

Publications (1)

Publication Number Publication Date
GR3024638T3 true GR3024638T3 (en) 1997-12-31

Family

ID=24608000

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970402276T GR3024638T3 (en) 1991-02-04 1997-09-04 Method for insuring adequate intracellular glutathione in tissue

Country Status (9)

Country Link
EP (1) EP0502313B1 (de)
JP (1) JPH04327537A (de)
AT (1) ATE155344T1 (de)
AU (1) AU652988B2 (de)
CA (1) CA2060560C (de)
DE (1) DE69220821T2 (de)
DK (1) DK0502313T3 (de)
ES (1) ES2106096T3 (de)
GR (1) GR3024638T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214062A (en) * 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
AU5040493A (en) * 1992-11-30 1994-06-09 Transcend Therapeutics, Inc Method for treating systemic inflammatory response syndrome
AU6060694A (en) * 1993-05-10 1994-11-17 Transcend Therapeutics, Inc Method for treating acquired immune deficiency syndrome
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
US5821217A (en) * 1995-10-27 1998-10-13 Beth Israel Deaconess Medical Center, Inc. Enteral formulation: low in fat and containing protein hydrolysates
US6251857B1 (en) 1995-12-14 2001-06-26 Novelos Therapeutics, Inc. Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
RU2089179C1 (ru) * 1995-12-14 1997-09-10 Закрытое акционерное общество "ВАМ" Стимулятор эндогенной продукции цитокинов и гепопоэтических факторов и способ его использования
RU2144374C1 (ru) 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
US20070142267A1 (en) 1998-11-23 2007-06-21 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
BRPI0414505A (pt) * 2003-09-19 2006-11-07 Nutricia Nv uso de carboidratos solúveis em água digerìveis e de um ou mais promotores da glutationa, e, composição
JP2006219458A (ja) * 2005-02-14 2006-08-24 Meiji Milk Prod Co Ltd 虚血性腸疾患抑制剤
JP5784869B2 (ja) * 2008-04-28 2015-09-24 太陽化学株式会社 抗炎症剤
CN101880702B (zh) * 2009-05-07 2012-12-12 成都自豪药业有限公司 一种采用产朊假丝酵母发酵生产谷胱甘肽的方法
KR102601321B1 (ko) * 2015-07-30 2023-11-10 메르크 파텐트 게엠베하 세포 내 글루타티온 수준을 증가시키는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (fr) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
FR2544613B1 (fr) * 1983-04-20 1985-10-25 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique, en reanimation et en therapeutique, renfermant une fraction proteique a base de trois types de minipeptides
EP0357776A4 (en) * 1987-05-14 1991-01-30 Terumo Kabushiki Kaisha Egg white hydrolyzate
CA1338682C (en) * 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement

Also Published As

Publication number Publication date
CA2060560C (en) 2002-07-23
ATE155344T1 (de) 1997-08-15
AU652988B2 (en) 1994-09-15
CA2060560A1 (en) 1992-08-04
DE69220821T2 (de) 1997-11-20
EP0502313B1 (de) 1997-07-16
AU1065992A (en) 1992-08-06
EP0502313A3 (en) 1993-05-12
ES2106096T3 (es) 1997-11-01
EP0502313A2 (de) 1992-09-09
JPH04327537A (ja) 1992-11-17
DE69220821D1 (de) 1997-08-21
DK0502313T3 (da) 1998-02-02

Similar Documents

Publication Publication Date Title
GR3024638T3 (en) Method for insuring adequate intracellular glutathione in tissue
ATE209864T1 (de) Zusammensetzung zur behandlung von patienten mit lebererkrankungen
ATE75945T1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
NO20000303L (no) Terapeutiske blandinger og diettblandinger inneholdende essensielle fettsyrer og bioaktive disulfider
ATE215320T1 (de) Nahrungszusammensetzungen in verschiedenen formen
DK642587D0 (da) Insulinpraeparat
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE68906153D1 (de) Humanes relaxinpraeparat.
KR910009246A (ko) 폴리펩타이드를 함유하는 피하투여용 또는 근육내 투여용 약제
MX9703642A (es) Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.
DK0851762T3 (da) Farmaceutiske kombinationspræparater, som indeholder erythropoietin og jernpræparater
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
GR3001922T3 (en) Use of n,n'-bis-l-amino acid-l-cystin peptides in amino acid preparations for oral and parenteral administration
WO1991015200A3 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
IL85346A0 (en) Pharmaceutical compositions containing human blood coagulation factor xiii
EP0351790A3 (de) Verfahren zur Bestimmung von Fructosamin
ATE96035T1 (de) Verwendung eines polypeptides mit gammainterferon-aktivitaet zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von primitivem pleura-krebs.
NZ243860A (en) Increasing glutathione levels in human and animal organs using whey protein concentrate